Skip to main content
. 2023 May 9;14:1137817. doi: 10.3389/fgene.2023.1137817

TABLE 1.

Clinical and laboratory data of the individuals studied.

Patient BMI (kg/m2) Age (Years) AHI (ev./h) Min Sat. (%) Mean Sat (%) Time below 90% Desat index (%) Arousal CPK Myogl (mcg/L) Snore Nose Brea Palate Mallampati Malocclusion (Class)
Family A
II.2 22.6 73 19.8 79.0 85.0 6.8 13.1 18.6 46.0 13.5 Present Satisf Ogival IV I
II.4 25.1 71 13.2 82.0 88.0 6.5 16.9 22.9 78.0 18.0 Present Satisf Ogival IV II
II.5 22.2 70 4.6 92.0 96.0 0.0 4.3 3.2 na na Present Satisf Ogival IV I
III.1 20.7 41 0.4 91.0 96.0 0.0 0.4 0.8 33.0 2.8 Present Satisf Ogival IV III
III.2 25.5 39 22.9 80.0 86.0 7.0 18.2 0.0 na na Present Satisf Ogival IV I
Family B
I.1 29.6 86 17.1 88 92 5.8 11.7 24.2 61.3 8.0 Present Satisf Ogival IV I
II.1 24.5 59 9.9 87 92 4.1 9.0 14.2 57.2 12.5 Present Satisf Ogival IV II
II.2 35.0 57 4.8 90 95 0.1 3.1 1.8 31.5 5.0 Absent Satisf Ogival IV I
II.3 33.8 50 23.3 85 89 6.3 13.5 19.6 na Na Present Satisf Ogival IV III
II.4 32.3 48 3.6 91 96 0.8 2.4 1.0 na na Absent Satisf Ogival III I

BMI, body mass index; AHI, Apnea–Hypopnea Index (events/hour); Min Sat. = Minimum Saturation %; Mean Sat. = Mean Saturation%; Desat Index = desaturation index %; CPK, serum creatine phosphokinase (Reference Value: Women: 26–140U/L, Man: 38–174U/L); Miogl = serum myoglobin (Reference Value: <90mcg/L); Nose Brea = nose breathing; Satisf = Satisfactory; na = not available.